Cision PR Newswire

Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board

CALGARY, AB, Sept. 29, 2026 /PRNewswire/ -- Providence Therapeutics Holdings, Inc. is pleased to announce formation of its initial Clinical Advisory Board. This advisory group will help steer Providence's therapeutic mRNA cancer vaccine programs, including the Company's personalized vaccine program for pediatric brain cancer patients as well as the...

Xingcai Launches New Global Website to Support International Expansion

JIEYANG, China, Sept. 29, 2026 /PRNewswire/ -- Xingcai, a manufacturer of stainless steel vacuum-insulated...

Meet Panda, Meet China: Travellers and Cultural Explorers Recognised for Sharing Personal Journeys

SYDNEY, Sept. 29, 2026 /PRNewswire/ -- Personal travel memories, music, family stories and everyday cultural...

Fostering new opportunities in the Greater Bay Area and Asia’s Pharmaceutical Industry

SHANGHAI, July 20, 2026 /PRNewswire/ -- Following the landmark success of CPHI & PMEC China in June 2026, which welcomed an unprecedented gathering of...

Launch of “ADPR EXPO 2027”: Thailand’s Inaugural Regional Disaster Management Exhibition Partners with “INTERSCHUTZ” to Elevate Comprehensive Public Safety

BANGKOK, July 20, 2026 /PRNewswire/ -- As environmental, urban, and technological risks continue to intensify, the demand for advanced disaster prevention and mitigation solutions...

Neuronata-R retains conditional approval in South Korea

South Korea's Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy's approval in May 2026 — as the developer works to...

Foreign entrepreneurs find business opportunities and a home in Yiwu

BEIJING, July 19, 2026 /PRNewswire/ -- A report from People's Daily: Yiwu, a city in east China's Zhejiang province, is neither a coastal...